DEVELOPMENT STRATEGY

The purpose of SPERCO is to produce efficient and safety pharmaceutical products applying the latest world industry achievements as the basis for profit gaining. SPERCO strategic plans include expanding its product portfolio (more than 20 new products are under development) and strengthening its positions on Ukrainian and international markets. SPERCO is planning to enter the list of TOP-10 Ukrainian pharmaceutical manufacturers in 2017!

MARKET INDICATORS

The company achieved significant results in the retail sector in 2016: sales volumes of SPERCO products made through pharmacies were 310,936 mln. UAH that allowed the company to climb from 42 to 37 place in the ranking of all pharmaceutical companies on Ukrainian market. If compare the company with national pharmaceutical companies, SPERCO confidently holds the position No 12, having risen to 3 points in the ranking over 2016. There are brand leaders in the company portfolio: Cardonat – leader among B group vitamins, Kremgen – leader among topical corticosteroids, Erotex – unchanged No1 brand among topical contraceptives and Noxprey – one of the leaders among nasal decongestants and the best known brand in its category.

OPPORTUNITIES FOR COOPERATION

SPERCO is an efficient team of like-minded people each of which being an expert in the area of his activity in the pharmaceutical business. Employees have long-term professional experience to improve current products and search for innovative and far-reaching decisions for the development of the pharmaceutical market in Ukraine and abroad. Our company is open to opportunities for cooperation in registration, import, production, marketing and promotion of pharmaceutical products. We will be glad to start mutually beneficial collaboration with Your company!

Kateryna Myrhorodska (marketing director)

phone: +38 067 434 87 32

E-mail: kateryna.myrhorodska@sperco.ua